6505--Fluticasone Propionate 50 MCG/Spray Soln, Nasal, 16GM
ID: 36E79725R0017Type: Solicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNAC PHARMACEUTICALS (36E797)HINES, IL, 60141, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/f738887f36ed4921a2992dd7f26f1f6d/view
Timeline
    Description

    The Department of Veterans Affairs is soliciting bids for the supply of Fluticasone Propionate nasal spray, a pharmaceutical product essential for various government healthcare facilities. Offerors are required to submit pricing for a base year and four option years, including a 0.5% Cost Recovery Fee, while ensuring compliance with federal standards and providing a unique National Drug Code (NDC) for each product. This procurement aims to secure reliable pharmaceutical sources to support healthcare services for veterans and other governmental health programs, adhering to strict FDA guidelines and good manufacturing practices. Interested contractors should contact Contract Specialist Michael J Olszewski at Michael.Olszewski@va.gov for further details on submission procedures and compliance requirements.

    Point(s) of Contact
    Michael J OlszewskiContract Specialist
    Michael.Olszewski@va.gov
    Files
    Title
    Posted
    36E79725R0017_1.docx
    The Department of Veterans Affairs (VA) is preparing to issue Request for Proposal (RFP) 36E79725R0017 for the procurement of Fluticasone Propionate 50 MCG/Spray solution, nasal, 16GM. This contract, intended for a variety of federal agencies including the VA, Department of Defense, Bureau of Prisons, and Indian Health Service, aims to secure a consistent supply of the medication for a period of one year, with the option for an additional four one-year extensions. The solicitation will be available electronically on or around February 11, 2025, with a closing date set for February 25, 2025. The procurement falls under NAICS code 325412, and interested vendors must provide specific product details, including the unique National Drug Code (NDC) associated with their offering. The estimated annual requirement is for approximately 5,784,828 bottles of Fluticasone Spray. Further amendments and details regarding the solicitation will be accessible online, and inquiries should be directed to the designated point of contact, Michael Olszewski.
    36E79725R0017.docx
    The document outlines a solicitation from the Department of Veterans Affairs seeking bids for the supply of Fluticasone Propionate nasal spray, a pharmaceutical product. It details the procurement process, emphasizing the necessity for offerors to submit prices for a base year and four option years, inclusive of a 0.5% Cost Recovery Fee. Eligibility is contingent upon submitting a unique National Drug Code (NDC) for each product and ensuring compliance with federal standards. The project is aimed at securing reliable pharmaceutical sources for various government healthcare facilities, including the Veterans Affairs, Department of Defense, Indian Health Service, and Bureau of Prisons. Contract terms enforce strict compliance with FDA guidelines, including drug recalls and good manufacturing practices. Additionally, the solicitation mandates reporting sales and payment of the Cost Recovery Fee, alongside maintaining contractual relationships with Prime Vendor programs for order fulfillment. Emphasis is placed on achieving volume pricing and ensuring product availability across government healthcare networks. The document serves as a comprehensive guide for potential contractors interested in fulfilling this government requirement, delineating submission procedures, compliance requirements, and contractual obligations. This ensures effective management and supply of pharmaceuticals in support of healthcare services for veterans and other specified governmental health programs.
    Similar Opportunities
    6505--Rituximab and Biosimilars
    Buyer not available
    The Department of Veterans Affairs is soliciting proposals for the procurement of Rituximab 10mg/ml and its biosimilars, aimed at establishing a reliable pharmaceutical supply source for government healthcare facilities. Bidders are required to provide unique National Drug Code (NDC) numbers for their products and include a 0.5% Cost Recovery Fee in their pricing, with the contract covering a base year and four optional subsequent years. This procurement is critical for ensuring consistent product availability and pricing based on estimated annual usage, while adhering to FDA regulations and the Drug Supply Chain Security Act (DSCSA) for safety and traceability. Interested suppliers must submit their proposals by March 11, 2025, at 2:30 PM CT, and can contact Contract Specialist Deborah S Fassl at Deborah.Fassl@va.gov for further information.
    6505--Diclofenac Sodium (NA) 1% Gel
    Buyer not available
    The Department of Veterans Affairs (VA) is soliciting proposals for the supply of Diclofenac Sodium (NA) 1% Gel, intended for use in its pharmaceutical programs as well as those of the Department of Defense (DoD). Contractors are required to provide pricing for a base year along with four one-year option years, ensuring compliance with federal drug regulations and the Drug Supply Chain Security Act (DSCSA). This procurement is critical for maintaining a reliable supply of pharmaceutical products that meet stringent manufacturing standards and public health requirements. Interested parties must submit their offers by March 4, 2025, at 2:30 PM Central Time, and can contact Contract Specialist Ray Roldan at Raymond.Roldan@va.gov for further information.
    6505--Bevacizumab Injection
    Buyer not available
    The Department of Veterans Affairs is soliciting proposals for the procurement of Bevacizumab injections, a critical pharmaceutical product used in various healthcare settings for veterans. Vendors are required to meet specific criteria, including providing unique National Drug Codes (NDC) and adhering to the Drug Supply Chain Security Act regulations, as the contract aims to ensure a reliable supply of this medication across government health care facilities. The selected contractor will be responsible for multiple line items of different Bevacizumab formulations, maintaining compliance with FDA manufacturing practices, and submitting quarterly sales reports, including cost recovery fees. Interested vendors should contact Contract Specialist Matthew S. Poulin at Matthew.Poulin@va.gov for further details, with submissions due by the specified deadlines outlined in the solicitation document.
    6505--Insulin (VA-25-00026482)
    Buyer not available
    The Department of Veterans Affairs is soliciting proposals for the procurement of insulin and related pharmaceutical products under the solicitation titled "6505--Insulin (VA-25-00026482)." This procurement aims to establish a reliable supply source for the Department of Veterans Affairs and the Department of Defense, requiring offerors to submit competitive pricing for a base year plus four option years, including a 0.5% Cost Recovery Fee. Compliance with the Drug Supply Chain Security Act (DSCSA), adherence to current good manufacturing practices (cGMP), and provision of unique National Drug Codes (NDC) for the offered products are critical requirements. Interested parties should direct inquiries to Contract Specialist Billy Fong at Billy.Fong@va.gov, with proposals due by the specified deadline outlined in the solicitation document.
    6505--Mycophenolate Mofetil RFP
    Buyer not available
    The Department of Veterans Affairs is seeking proposals for the procurement of Mycophenolate Mofetil capsules and tablets under Solicitation Number 36E79725R0010, aimed at establishing national pricing for these pharmaceutical products. The contract is intended to support various government health care facilities, including those under the Department of Defense and Indian Health Service, ensuring compliance with FDA standards and the Drug Supply Chain Security Act. Offerors are required to submit pricing for both the base year and four option years, with a deadline for submissions extended to March 4, 2025, at 2:30 PM CST, and must acknowledge receipt of this amendment to avoid rejection of their offers. Interested parties can contact Contract Specialist Amber Zavala at amber.zavala@va.gov for further information.
    6509--Solifenacin Tabletes (VA-25-00037090)
    Buyer not available
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Solifenacin Tablets, designated as RFP 36E79725R0020. This procurement aims to establish a reliable supply of Solifenacin for the VA, Department of Defense (DoD), and other federal health agencies, with the contract expected to last one year and include four optional renewal periods. Solifenacin is a critical medication used in the treatment of overactive bladder, highlighting the VA's commitment to ensuring access to essential pharmaceuticals for veterans and associated healthcare providers. Interested vendors should monitor SAM.gov for the RFP release, anticipated around March 14, 2025, with proposals due by March 28, 2025; for further inquiries, they may contact Contract Specialist Kenneth Lay at Kenneth.Lay@va.gov or by phone at 708-786-4879.
    6505--CAMPHOR_MENTHOL_METHYL SALICYLATE PATCH
    Buyer not available
    The Department of Veterans Affairs is soliciting proposals for the procurement of Camphor-Menthol-Methyl Salicylate Patches, aimed at enhancing the medical supplies available for veterans. This Request for Proposals (RFP) outlines the need for pharmaceutical supplies, emphasizing compliance with federal regulations, including product labeling and delivery schedules, while prioritizing small businesses, particularly those owned by veterans or women. The patches are essential for providing pain relief to veterans, ensuring they receive effective treatment options. Interested bidders must submit their proposals, including pricing and required documentation, to Contract Specialist Larry M Zaritz at larry.zaritz@va.gov, with the procurement being unrestricted and adhering to the Drug Supply Chain Security Act.
    6505--Hydroxychloroquine SO4 Tablets
    Buyer not available
    The Department of Veterans Affairs (VA) is issuing a Request for Proposal (RFP) for the procurement of Hydroxychloroquine SO4 Tablets, aimed at ensuring a continuous supply for various federal entities, including the Department of Defense and the Bureau of Prisons. The contract will cover an estimated annual requirement of 163,395 bottles of 100-count and 25,853 bottles of 500-count Hydroxychloroquine tablets, with a contract period of one year and four optional one-year extensions. This procurement is critical for maintaining essential medications within veteran and federal healthcare programs. Interested parties should monitor SAM.gov for updates and direct inquiries to the contracting officer, Chris Carthron, at Christopher.Carthron@va.gov or (708) 786-4980, with submissions due by March 26, 2025.
    6505--770-25-1-801-0131 -National CMOP DORZOLAMIDE/TIMOLOL -(VA-25-00027395)
    Buyer not available
    The Department of Veterans Affairs is soliciting bids for the procurement of Dorzolamide 22.3/Timolol 6.8mg/ml ophthalmic solution as part of its National Consolidated Mail Outpatient Pharmacy (CMOP) program. This solicitation requires vendors to submit a signed cover page, pricing schedule, and documentation such as a valid state distributor license and a Trade Agreements Act certificate, ensuring compliance with regulatory standards for pharmaceutical products. The procurement is critical for providing quality healthcare services to veterans, emphasizing the importance of product safety, therapeutic equivalence, and adherence to delivery schedules. Interested vendors must submit their quotes by March 5, 2025, at 3:00 PM Central Time, and can contact Contract Specialist Kelley Cunningham at kelley.cunningham@va.gov for further inquiries.
    6505--762_Pharmaceuticals_VA CMOP Tucson_36C77025Q0168 762-25-2-040-1176 -Tucson CMOP HYDROXYCHLOROQUINE SULFATE
    Buyer not available
    The Department of Veterans Affairs is seeking proposals for the procurement of Hydroxychloroquine Sulfate 200mg tablets, with a total quantity of 5,412 to be delivered to the CMOP facility in Tucson, Arizona. This presolicitation, identified by solicitation number 36C77025Q0168, is set aside for small businesses and requires compliance with the Buy American statute, necessitating quotes for both foreign and domestic products. Hydroxychloroquine is a critical pharmaceutical used in the treatment of various conditions, making this procurement essential for the healthcare services provided to veterans. Interested vendors must submit their proposals by March 5, 2025, at 09:00 Central Time, and can direct inquiries to Contract Specialist Michael W. McAlhaney via email at Michael.McAlhaney@va.gov or by phone at (913) 684-0134.